M&A Deal Summary

Strides Pharma Science Acquires PediaCare

On November 25, 2016, Strides Pharma Science acquired life science company PediaCare from Moberg Pharma for 5M USD

Acquisition Highlights
  • This is Strides Pharma Science’s 2nd transaction in the Life Science sector.
  • This is Strides Pharma Science’s 2nd largest (disclosed) transaction.
  • This is Strides Pharma Science’s 1st transaction in the United States.
  • This is Strides Pharma Science’s 1st transaction in New York.

M&A Deal Summary
Date 2016-11-25
Target PediaCare
Sector Life Science
Buyer(s) Strides Pharma Science
Sellers(s) Moberg Pharma
Deal Type Divestiture
Deal Value 5M USD

Target

PediaCare

Staten Island, New York, United States
PediaCare is a provider of products for children, primarily within cough cold and analgesics segments.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Strides Pharma Science

Bangalore, India
Category Company
Founded 1990
Sector Life Science
Employees2,390
Revenue 40.5B INR (2024)
DESCRIPTION

Strides Pharma Science is a pharmaceutical company. Strides operates in pharma generics, branded generics, and biopharma. Strides Pharma Science was founded in 1990 and is based in Bangalore, India.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 2 of 2
Type (Divestiture) 1 of 1
State (New York) 1 of 1
Country (United States) 1 of 1
Year (2016) 1 of 1
Size (of disclosed) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-12-04 Agila Specialties Pvt.

Bengaluru, India

Agila Specialties Private Limited, a developer, manufacturer and marketer of high-quality generic injectable products.

Sell $1.8B

Seller(S) 1

SELLER

Moberg Pharma

Bromma, Sweden
Category Company
Founded 2006
Sector Medical Products
Employees9
Revenue 439M SEK (2018)
DESCRIPTION

Moberg Pharma is a Swedish pharmaceutical company with direct sales through its own sales organization in the US and sales through distributors in more than 35 countries. The company’s product portfolio includes topical products for the treatment of skin disorders and pain under the brands Kerasal®, Jointflex®, Kerasal Nail® and Kaprolac®. Kerasal Nail® (Nalox™ in many markets) is the leading product for the treatment of nail disorders in the Nordic market. Moberg Pharma was founded in 2006 and is based in Bromma, Sweden.

DEAL STATS #
Overall 1 of 3
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 3
State (New York) 1 of 1
Country (United States) 1 of 3
Year (2016) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-06-30 Fiber Choice

Cedar knolls, New Jersey, United States

Fiber Choice is a provider of digestive health with a compelling line up of product options for daily fiber supplementation. Fiber Choice is based in Cedar Knolls, New Jersey.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-08-21 Fiber Choice

Cedar knolls, New Jersey, United States

Fiber Choice is a provider of digestive health with a compelling line up of product options for daily fiber supplementation. Fiber Choice is based in Cedar Knolls, New Jersey.

Sell -
Mergr

Product

Company

Legal